Elanco Animal Health Incorporated Variable Lease, Cost
Elanco Animal Health Incorporated (ELAN) reported Variable Lease, Cost of $4.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2024-02-26
- Elanco Animal Health Incorporated variable lease, cost for the quarter ending 2019-12-31 was $400.00K.
- Elanco Animal Health Incorporated variable lease, cost for the quarter ending 2019-09-30 was $500.00K.
- Elanco Animal Health Incorporated variable lease, cost for the quarter ending 2019-06-30 was $600.00K.
- Elanco Animal Health Incorporated variable lease, cost for the quarter ending 2019-03-31 was $500.00K.
- Elanco Animal Health Incorporated variable lease, cost for fiscal 2023 was $4.00M, a 20.00% decline from fiscal 2022.
- Elanco Animal Health Incorporated variable lease, cost for fiscal 2022 was $5.00M, a 25.00% increase from fiscal 2021.
- Elanco Animal Health Incorporated variable lease, cost for fiscal 2021 was $4.00M, a 33.33% increase from fiscal 2020.
- Elanco Animal Health Incorporated variable lease, cost for fiscal 2020 was $3.00M, a 50.00% increase from fiscal 2019.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $4.00M 10-K · filed 2024-02-26 | ||||
| 2022-12-31 | $5.00M 10-K · filed 2024-02-26 | ||||
| 2021-12-31 | $4.00M 10-K · filed 2024-02-26 | ||||
| 2020-12-31 | $3.00M 10-K · filed 2023-03-01 | $2.80M 10-K · filed 2021-03-01 | |||
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $900.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.50M derived: sum of 3 quarters · filed 2022-02-28 | $2.00M 10-K · filed 2022-02-28 | $2.50M 10-K · filed 2020-02-28 |
| 2019-09-30 | $500.00K 10-Q · filed 2019-11-08 | $1.10M derived: sum of 2 quarters · filed 2019-11-08 | $1.60M 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $600.00K 10-Q · filed 2019-08-13 | $1.10M 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $500.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |